The startup utilizes epigenetic analysis to predict cancer risk, enabling personalized prevention strategies based on individual genetic markers. This approach addresses the challenge of early cancer detection by providing actionable insights that can lead to timely interventions.
Funding
$417.3K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for assessing women's health often lack the precision needed for early and accurate diagnoses. This can lead to delayed interventions and less effective treatment strategies.
Solution
The startup offers precision diagnostics for women's health, leveraging advanced analytical techniques. Their approach aims to provide more accurate and timely insights into individual health risks, enabling personalized prevention and treatment plans. By focusing on precision, they strive to improve diagnostic accuracy and ultimately enhance women's healthcare outcomes.
Target Audience
The primary target audience is women seeking proactive and precise health assessments, as well as healthcare providers specializing in women's health.
Features
- Advanced analytical techniques for precise health assessments
- Personalized prevention strategies based on individual risk profiles
- Early detection capabilities for timely interventions